IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices in the United States...
| Metric Name | Value | Trend | |
|---|---|---|---|
| Dividend Yield | 1.3% | ||
| P/E Ratio | 34.0x | ||
| Revenue | 73.242 M | ||
| Net Income to Company | 19.234 M |
| IRMD | Peers | Sector | |
|---|---|---|---|
Market Cap | 666.9 M | 67.04 M | 64.23 M |
Price % of 52 Week High | 82.9% | 51.8% | 61.6% |
Dividend Yield | 1.3% | 0.0% | 0.0% |
Shareholder Yield | 2.5% | -19.2% | -0.6% |
1 Year Price Total Return | 22.0% | -15.5% | -11.6% |
Beta (5 Year) | 0.84 | 1.15 | 0.64 |
| (presentment in millions) | Trailing Twelve Months | Fiscal Quarters | |||
|---|---|---|---|---|---|
| Period Ending | Dec-22 | Dec-23 | Dec-24 | Dec-23 | Dec-24 |
| Income Statement | |||||
| Revenue | 53 | 66 | 73 | 17 | 19 |
| Operating Income | 16 | 20 | 22 | 5.16 | 5.80 |
| Net Profit | 13 | 17 | 19 | 4.54 | 5.15 |
| Diluted EPS | 1.02 | 1.35 | 1.50 | 0.36 | 0.40 |
| EBITDA | 16 | 21 | 23 | 5.37 | 6.00 |
| Balance Sheet | |||||
| Cash & ST Invest. | 58 | 50 | 52 | 50 | 52 |
| Current Assets | 77 | 76 | 75 | 76 | 75 |
| Total Assets | 86 | 92 | 98 | 92 | 98 |
| Current Liabilities | 8.55 | 16 | 8.51 | 16 | 8.51 |
| Total Liabilities | 12 | 21 | 12 | 21 | 12 |
| Total Equity | 74 | 71 | 87 | 71 | 87 |
| Total Debt | 2.21 | 2.04 | 0.15 | 2.04 | 0.15 |
| Cash Flow Statement | |||||
| Cash Flow Operations | 10 | 13 | 26 | 3.91 | 5.99 |
| Cash From Investing | (1.37) | (8.01) | (8.82) | (0.63) | (3.06) |
| Cash From Financing | (13) | (14) | (14) | (0.26) | (2.42) |
| Free Cash Flow | 9.22 | 6.02 | 18 | 3.38 | 3.20 |